Eisai launches Leqembi to treat early Alzheimer’s disease

· thehindubusinessline.com

Eisai launches Leqembi in India to treat early Alzheimer's, addressing dementia in millions with innovative therapy and ongoing studies.

Japan-headquartered Eisai has launched Leqembi (lecanemab) for the treatment of early Alzheimer’s disease, in India.

The product is indicated for patients wi...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI